Clinitech Laboratory Ltd vs Kwick Forensic Solutions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 32 as of 07 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 .The P/E Ratio of Kwick Forensic Solutions Ltd is 0 as of March 2025 . The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 .The Market Cap of Kwick Forensic Solutions Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Kwick Forensic Solutions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai and was converted to Public Limited on August 25, 2023.
The Company is in the business of healthcare services providing quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.
Clinical pathology is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues.

About Kwick Forensic Solutions Ltd

Kwick Forensic Solutions Limited was initially incorporated as 'Kwick Soft Solutions Private Limited' as a Private Company on March 4, 2005 with the Registrar of Companies, Tamil Nadu.
Later, the name of the Company got changed from 'Kwick Soft Solutions Private Limited' to 'Kwick Integrated Forensic and Investigation Solutions Private Limited' on July 08, 2024 and again changed to 'Kwick Forensic Solutions Private Limited' on September 16, 2024.
Now, the Company has got status converted to Public Limited Company via fresh Certificate of Incorporation issued by the Central Processing Centre on April 29, 2025. Company provides end-to-end forensic products and services across four segments-Forensic Science & Physical Evidence Solutions, Mobile CSI Vehicles, Cyber & Digital Forensics, and DNA Forensics-together with a services line for liquor detection scanner with manpower support.

FAQs for the comparison of Clinitech Laboratory Ltd and null

Which company has a larger market capitalization, Clinitech Laboratory Ltd or Kwick Forensic Solutions Ltd?

Market cap of Clinitech Laboratory Ltd is 7 Cr while Market cap of Kwick Forensic Solutions Ltd is 405 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and Kwick Forensic Solutions Ltd?

The stock performance of Clinitech Laboratory Ltd and Kwick Forensic Solutions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and Kwick Forensic Solutions Ltd?

As of October 25, 2026, the Clinitech Laboratory Ltd stock price is INR ₹32.0. On the other hand, Kwick Forensic Solutions Ltd stock price is INR ₹188.95.

How do dividend payouts of Clinitech Laboratory Ltd and Kwick Forensic Solutions Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and Kwick Forensic Solutions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.